BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1681110)

  • 1. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
    Pearson JW; Fogler WE; Volker K; Usui N; Goldenberg SK; Gruys E; Riggs CW; Komschlies K; Wiltrout RH; Tsuruo T
    J Natl Cancer Inst; 1991 Oct; 83(19):1386-91. PubMed ID: 1681110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
    Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
    J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
    J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M; Tsuge H; Kuroko C; Tomida A; Tsuruo T
    Jpn J Cancer Res; 1993 May; 84(5):489-92. PubMed ID: 8100562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
    Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
    J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein.
    Matsuo H; Wakasugi M; Takanaga H; Ohtani H; Naito M; Tsuruo T; Sawada Y
    J Control Release; 2001 Nov; 77(1-2):77-86. PubMed ID: 11689261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16, and their synergistic modulation of multidrug resistance].
    Naito M; Tsuruo T
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):395-402. PubMed ID: 7906507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.
    Danova M; Giordano M; Erba E; Palmeri S; Candiloro V; Riccardi A; Ucci G; Mazzini G; D'Incalci M; Ascari E
    J Cancer Res Clin Oncol; 1992; 118(8):575-80. PubMed ID: 1355483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft.
    Rittmann-Grauer LS; Yong MA; Sanders V; Mackensen DG
    Cancer Res; 1992 Apr; 52(7):1810-6. PubMed ID: 1348013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
    Watanabe T; Naito M; Kokubu N; Tsuruo T
    J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody.
    Scott AM; Rosa E; Mehta BM; Divgi CR; Finn RD; Biedler JL; Tsuruo T; Kalaigian H; Larson SM
    Nucl Med Biol; 1995 May; 22(4):497-504. PubMed ID: 7550027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein.
    Broxterman HJ; Kuiper CM; Schuurhuis GJ; Tsuruo T; Pinedo HM; Lankelma J
    Biochem Pharmacol; 1988 Jun; 37(12):2389-93. PubMed ID: 2898943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody.
    Georges E; Tsuruo T; Ling V
    J Biol Chem; 1993 Jan; 268(3):1792-8. PubMed ID: 7678410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression behavior of 85-kDa membrane protein in adriamycin-resistant tumor cells and the inhibition of human tumor growth in athymic mice by MRK-20 monoclonal antibody against the protein.
    Ishii S; Naito M; Tsuruo T
    Jpn J Cancer Res; 1993 Jul; 84(7):776-82. PubMed ID: 8370652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
    Kulkarni SS; Wang ZM; Spitzer G; Taha M; Hamada H; Tsuruo T; Dicke KA
    Blood; 1989 Nov; 74(6):2244-51. PubMed ID: 2572283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice.
    Yano S; Hanibuchi M; Nishioka Y; Nokihara H; Nishimura N; Tsuruo T; Sone S
    Int J Cancer; 1999 Jul; 82(1):105-11. PubMed ID: 10360828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of multidrug resistant cells in human malignant diseases by monoclonal antibodies and strategy to eradicate resistant malignant cells].
    Shimoyama M; Ohtsu T; Ishida Y; Shimada Y; Tobinai K; Minato K; Tsuruo T
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):611-6. PubMed ID: 2565103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-define proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas.
    Sugawara I; Kodo H; Ohkochi E; Hamada H; Tsuruo T; Mori S
    Br J Cancer; 1989 Oct; 60(4):538-41. PubMed ID: 2572270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.
    Barrand MA; Twentyman PR
    Br J Cancer; 1992 Feb; 65(2):239-45. PubMed ID: 1346747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.